“I think it’s really important that people keep signing up to these type of trials to push research forward.”
A trial comparing chemotherapy with no further treatment after surgery to remove sarcoma of the womb
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This trial was for women who have had surgery to remove their womb to treat a type of cancer called leiomyosarcoma. The trial compared chemotherapy after surgery with no further treatment. Cancer Research UK supported this trial.
More about this trial
If you have your womb removed (a
Most women will remain cancer free, but sometimes the cancer does come back. If this happens, you may have chemotherapy. There are several chemotherapy drugs that doctors can use, including a combination of the 2 drugs gemcitabine and docetaxel (Taxotere), and another drug called doxorubicin.
In this trial, researchers wanted to see if having these chemotherapy drugs after surgery to remove leiomyosarcoma reduced the chance of the cancer coming back.
Summary of results
This trial closed early as the researchers were unable to get enough women to take part. Because of this the trial team are not able to produce any significant results.
How to join a clinical trial
Dr Helen Hatcher
Cancer Research UK
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/11/051.